Gregory A. Storch

16.9k total citations · 3 hit papers
229 papers, 11.5k citations indexed

About

Gregory A. Storch is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Gregory A. Storch has authored 229 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Epidemiology, 97 papers in Infectious Diseases and 34 papers in Oncology. Recurrent topics in Gregory A. Storch's work include Cytomegalovirus and herpesvirus research (49 papers), Respiratory viral infections research (39 papers) and Herpesvirus Infections and Treatments (38 papers). Gregory A. Storch is often cited by papers focused on Cytomegalovirus and herpesvirus research (49 papers), Respiratory viral infections research (39 papers) and Herpesvirus Infections and Treatments (38 papers). Gregory A. Storch collaborates with scholars based in United States, Australia and Thailand. Gregory A. Storch's co-authors include Monique Gaudreault‐Keener, Daniel C. Brennan, Richard S. Buller, Kristine M. Wylie, David B. Clifford, George M. Weinstock, Mark A. Schnitzler, Karen L. Hardinger, Daniel L. Bohl and Max Q. Arens and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Gregory A. Storch

227 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction

2005 540 citations Daniel C. Brennan, Monique Gaudreault‐Keener et al. profile →
Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections

2007 503 citations Anne M. Gaynor, Michael D. Nissen et al. PLoS Pathogens profile →
Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles

2023 130 citations Gregory A. Storch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory A. Storch United States	60	5.1k	4.6k	2.6k	1.4k	1.1k	229	11.5k
Ajit P. Limaye United States	55	5.5k 1.1×	3.1k 0.7×	2.7k 1.0×	869 0.6×	610 0.5×	182	9.3k
Thomas F. Smith United States	57	6.6k 1.3×	2.6k 0.6×	1.5k 0.6×	486 0.3×	1.0k 0.9×	232	10.2k
Theo P. Sloots Australia	50	3.8k 0.7×	2.6k 0.6×	1.2k 0.5×	231 0.2×	592 0.5×	194	7.5k
Michael D. Nissen Australia	52	4.1k 0.8×	2.9k 0.6×	901 0.3×	257 0.2×	527 0.5×	172	7.7k
Atul Humar Canada	67	10.6k 2.1×	4.1k 0.9×	2.9k 1.1×	1.0k 0.7×	560 0.5×	275	14.4k
David Brown United Kingdom	67	4.7k 0.9×	7.8k 1.7×	1.2k 0.5×	298 0.2×	414 0.4×	251	13.2k
William D. Rawlinson Australia	62	7.7k 1.5×	5.5k 1.2×	1.1k 0.4×	631 0.4×	1.4k 1.2×	410	15.0k
Raphael P. Viscidi United States	58	5.9k 1.2×	2.0k 0.4×	3.2k 1.2×	294 0.2×	2.0k 1.8×	230	13.2k
Fausto Baldanti Italy	55	7.1k 1.4×	5.8k 1.2×	2.0k 0.7×	863 0.6×	900 0.8×	434	12.3k
James J. Sejvar United States	49	2.6k 0.5×	4.1k 0.9×	588 0.2×	756 0.5×	1.2k 1.1×	150	9.2k

Countries citing papers authored by Gregory A. Storch

Since Specialization

Citations

This map shows the geographic impact of Gregory A. Storch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Storch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Storch more than expected).

Fields of papers citing papers by Gregory A. Storch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Storch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Storch. The network helps show where Gregory A. Storch may publish in the future.

Co-authorship network of co-authors of Gregory A. Storch

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Storch. A scholar is included among the top collaborators of Gregory A. Storch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory A. Storch. Gregory A. Storch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Acosta, Edward P., Inmaculada Aban, Kevin J. Ryan, et al.. (2025). Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study. The Journal of Infectious Diseases.

Bacharier, Leonard B., Daniel J. Jackson, David T. Mauger, et al.. (2023). The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With Asthma. CHEST Journal. 164(2). 302–313. 13 indexed citations

Jhaveri, Ravi, Felice C. Adler‐Shohet, Christopher C. Blyth, et al.. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society. 10(10). 937–939. 5 indexed citations

Patel, Robin, Esther Babady, Elitza S. Theel, et al.. (2020). Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19. mBio. 11(2). 262 indexed citations

Hartwick, Andrew T. E., Ellen Shorter, Jennifer Harthan, et al.. (2019). Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis. Investigative Ophthalmology & Visual Science. 60(9). 6257–6257. 2 indexed citations

Hatch, Joseph, James E. Slaven, Gregory A. Storch, et al.. (2019). Early respiratory viral infections in infants with cystic fibrosis. Journal of Cystic Fibrosis. 18(6). 844–850. 28 indexed citations

Schwartz, Drew J., Alexis Elward, Gregory A. Storch, & David A. Rosen. (2018). Ureaplasma urealyticum pyelonephritis presenting with progressive dysuria, renal failure, and neurologic symptoms in an immunocompromised patient. Transplant Infectious Disease. 21(2). e13032–e13032. 10 indexed citations

Pastula, Daniel M., Amy J. Lambert, J. Erin Staples, et al.. (2018). Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA. Emerging infectious diseases. 24(5). 893–897. 19 indexed citations

Hampton, Nicholas, David J. Ritchie, Richard S. Buller, et al.. (2015). Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Critical Care. 19(1). 404–404. 29 indexed citations

10.

Simpson, Kathleen E., Gregory A. Storch, Caroline K. Lee, et al.. (2013). BLOOD VIRAL PCR FREQUENTLY IDENTIFIES CARDIOTROPIC VIRUSES IN PEDIATRIC PATIENTS WITH CLINICAL MYOCARDITIS OR RECENT ONSET DILATED CARDIOMYOPATHY AT TIME OF PRESENTATION. Journal of the American College of Cardiology. 61(10). E1264–E1264. 2 indexed citations

11.

Muenzer, Jared T., David M. Jaffe, Elena Deych, et al.. (2012). Detection of Viruses in Young Children With Fever Without an Apparent Source. PEDIATRICS. 130(6). e1455–e1462. 64 indexed citations

12.

Wylie, Kristine M., Kathie A. Mihindukulasuriya, Erica Sodergren, George M. Weinstock, & Gregory A. Storch. (2012). Sequence Analysis of the Human Virome in Febrile and Afebrile Children. PLoS ONE. 7(6). e27735–e27735. 139 indexed citations

13.

Kimberlin, David W., Mark J. Abzug, David J. Lang, et al.. (2010). Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age. The Pediatric Infectious Disease Journal. 29(3). 195–198. 32 indexed citations

14.

Fritz, Stephanie A., et al.. (2008). Prevalencia y factores de riesgo de colonización por Staphylococcus aureus resistente y sensible a meticilina adquirido en la comunidad en niños visitados en una consultade pediatría afiliada a una red de investigación basada en consultorios. PEDIATRICS. 65(6). 291–299. 3 indexed citations

15.

Gaynor, Anne M., Michael D. Nissen, David M. Whiley, et al.. (2007). Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections. PLoS Pathogens. 3(5). e64–e64. 503 indexed citations breakdown →

16.

Sweet, Stuart C., et al.. (2006). Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients. Pediatric Transplantation. 11(3). 312–318. 16 indexed citations

17.

Buller, Richard S., Max Q. Arens, S. Paul Hmiel, et al.. (1999). Ehrlichia ewingii,a Newly Recognized Agent of Human Ehrlichiosis. New England Journal of Medicine. 341(3). 148–155. 300 indexed citations

18.

Kruger, Robert M., William D. Shannon, Max Q. Arens, et al.. (1999). THE IMPACT OF GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION AFTER LUNG TRANSPLANTATION. Transplantation. 68(9). 1272–1279. 77 indexed citations

19.

Gruber, William C., Gregory A. Storch, Gail J. Demmler, et al.. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology & Therapeutics. 53(1). 15–21. 70 indexed citations

20.

Harrington, Robert, Thomas M. Hooton, Robert C. Hackman, et al.. (1992). An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant Center. The Journal of Infectious Diseases. 165(6). 987–993. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact